期刊文献+

白色念珠菌ERG11突变基因在毕氏酵母中的表达

Expression of Candida albicans point mutant ERG11 gene in Pichia pastoris
原文传递
导出
摘要 目的将含有点突变的白色念珠菌编码基因ERG11克隆至毕氏酵母中进行表达,判断其在白色念珠菌对氟康唑敏感性中的作用。方法将含有点突变的白色念珠菌编码基因ERG11与pPm3.5K载体重组,构建pPiC3.5K/Ca1.6k重组体,经Top10F’鉴定和筛选,电转入毕氏酵母GS115中,经过诱导表达出现目的蛋白后,进行药物敏感性试验,确定点突变与耐药的关系。结果含Y132H突变转化菌株和含Q474K突变的转化菌株对氟康唑的MIC分别上升16倍和8倍,证实其突变与耐药有关。结论氟康唑耐药可发生于白色念珠菌编码基因ERG11的Y132H与Q474K点突变中。 Objective To study the relation between the point mutation of Candida albicans ERGll gene and fluconazole susceptibihty. Method ERGll gene was cloned into pPIC3.5K vector, formed the pPIC3.5K/Ca1.6k, then transformed into Pichia pastoris GSll5 and expressed in various condition. Results The susceptibihty test manifested to Y132H mutation increased by 16 folds MIC and Q474K mutation 8 folds respectively. Condusions Resistance to fluconazole may occur through the Y132H point mutation and Q474K point mutation of Candida albicans gene ERGll respectively.
出处 《国际流行病学传染病学杂志》 CAS 2008年第2期78-81,85,共5页 International Journal of Epidemiology and Infectious Disease
基金 国家自然科学基金(39870011)
关键词 念珠菌 白色 ERG11 毕氏酵母 功能表达 耐药性 Candida albicarts ERG11 Pichia pastoris Function expression Drug resistance
  • 相关文献

参考文献13

  • 1Lee MD, Galazzo JL, Staley AL, et al. Microbial fermentation-derived inhibitors of efflux-pump-mediated drug resistance. Farmaco, 2001, 56(1/2): 81-85.
  • 2White TC, Holleman S, Dy F, et al. Rrsistance mechanisms in clinical isolates of Canadida albicans. Antimicrob Agents Chemother, 2002, 46(4): 1704-1713.
  • 3Lamb DC, Kelly DE, White TC, et al. The R467K amino acid substitution in C, andida albicans sterol 14alpha-demethylase causes drug resistance through reduced affinity. Antimicrob Agents Chemother, 2000, 44(1): 63-67.
  • 4Mishra NN, Prasad T, Sharma N, et al. Pathogenicity and drug resistance in Candida albicans and other yeast species. A review. Acta Microbiol Immunol Hung, 2007, 54(3):201-235.
  • 5Asai K, Tsuchimori N, Okonogi K, et al. Formation of azole resistant Candida albicans by mutation of sterol 14-demethylase P450. Anti microb Agents Chemother, 1999, 43 (5): 1163-1169.
  • 6Edlind TD, Henry KW, Metera KA, et al. Aspergillus fumigatus CYPS1 sequence: potential basis for fluconazol eresistance. Med Mycol, 2001, 39(3): 299-302.
  • 7Sanglard D, Ischer F, Koymans L, et al. Aminoacid substitution in the cytochrome P450 lanosterol 14 alpha-demethylase( CYP51A1 ) from azole resistant Candida albicans clinical isolates contribute to resistance to azole antifungal agents. Antimicrob Agents Chemother, 1998, 42(2) :241-253.
  • 8龙丰,张永信,兰和魁,王荫榆,朱德妹,任大明.耐氟康唑白念珠菌ERG11的基因突变[J].中华传染病杂志,2002,20(4):211-214. 被引量:14
  • 9Brocca S, Schmidt-Dannert C, Lotti M, et al. Design, total synthesis and functional overexpression of the Candida rugosa lipl gene coding for a major industrial lipase. Protein Sci, 1998, 7(6) : 1415-1422.
  • 10Perea S, Lopez-Ribot JL, Kirkpatriek WR, et al. Prevalence of molecular mechanisms of resistance to azole antifungal agents in Candida albicans strains displaying high-level fluconazole reisistance isolated titan human immunodeficiency virus infected patients. Antimicrob Agents Chemother, 2001, 45(10): 2676-2684.

二级参考文献2

共引文献13

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部